The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shivnan, E.
Right arrow Articles by Alexander, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shivnan, E.
Right arrow Articles by Alexander, D. R.

The Journal of Immunology, Vol 157, Issue 1 101-109, Copyright © 1996 by American Association of Immunologists


ARTICLES

CD45 monoclonal antibodies inhibit TCR-mediated calcium signals, calmodulin-kinase IV/Gr activation, and oncoprotein 18 phosphorylation

E Shivnan, L Clayton, L Allridge, KE Keating, M Gullberg and DR Alexander
Department of Immunology, The Babraham Institute, Cambridge, United Kingdom.

The effects of a pan-CD45 mAb (CD45.2) on TCR-mediated signaling pathways were investigated in Jurkat T cells. The simultaneous addition of CD45 mAb with an activating OKT3 mAb had little effect on TCR- stimulated signals. However, when Jurkat cells were exposed to the CD45 mAb for 10 to 20 min before the addition of OKT3, a partial uncoupling of the TCR from intracellular signals was observed. The maximal increase in intracellular calcium was inhibited 47 +/- 10% (n = 11, range 33-67%), whereas no inhibition of inositol trisphosphate production was detected. The transient TCR-mediated activation of the Ca2+/calmodulin-activated kinase IV/Gr was also inhibited by the CD45 mAb, and this was reflected in a 50 to 60% inhibition in the TCR- stimulated generation of the p21 and p23 phosphoisomers of oncoprotein 18, a Ca2+/calmodulin-activated kinase IV/Gr substrate recently implicated in cell cycle regulatory events. Oncoprotein 18 is also a substrate for mitogen- activated protein kinase, but no inhibition by the CD45 mAb of TCR-triggered mitogen-activated protein kinase activation was observed. The CD45 mAb was therefore selective in causing the uncoupling of the TCR from calcium signals and calcium- regulated events without promoting a general inhibition of all TCR- mediated signals. Confocal microscopy revealed that binding of the CD45 mAb caused patching of CD45 molecules at the cell surface and, unexpectedly, a marked redistribution of intracellular CD45. However, no change was observed in the total level of CD45 expressed at the cell surface. Aggregation of CD45 at the cell surface may result in its sequestration from its tyrosine kinase substrates, with a consequent selective uncoupling of the TCR from intracellular signaling pathways.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Rachmilewitz, Z. Borovsky, G. J. Riely, R. Miller, and M. L. Tykocinski
Negative Regulation of T Cell Activation by Placental Protein 14 Is Mediated by the Tyrosine Phosphatase Receptor CD45
J. Biol. Chem., April 11, 2003; 278(16): 14059 - 14065.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Barbeau, G. A. Robichaud, J.-F. Fortin, and M. J. Tremblay
Negative Regulation of the NFAT1 Factor by CD45: Implication in HIV-1 Long Terminal Repeat Activation
J. Immunol., September 1, 2001; 167(5): 2700 - 2713.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. Arendt and H. L. Ostergaard
Identification of the CD45-associated 116-kDa and 80-kDa Proteins as the alpha - and beta -Subunits of alpha -Glucosidase II
J. Biol. Chem., May 16, 1997; 272(20): 13117 - 13125.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.